Free Trial
OTCMKTS:POSC

Positron Q2 2026 Earnings Results & Report

Positron logo
$1.64 -0.05 (-2.96%)
As of 01:48 PM Eastern

Positron reported Q2 2026 earnings on August 14, 2026. The company reported EPS of -$0.03, while revenue was $110 thousand.

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
After Market Closes

Positron EPS Results

Actual EPS
-$0.03
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Positron Revenue Results

Actual Revenue
$110 thousand
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Positron Q2 2026 Earnings FAQ

Positron (OTCMKTS:POSC) reported earnings of -$0.03 per share for Q2 2026. The report was announced on Friday, August 14, 2026.

Positron reported revenue of $110 thousand for Q2 2026.

Positron Earnings Headlines

Positron Corp Stock Price History
You missed yesterday's deadline…
In June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times the output of Saudi Arabia's largest oil well, enough potential energy to power civilization for two million years. While the One Big Beautiful Bill Act stripped tax credits from solar, wind, and EVs on July 4th, this discovery was reclassified alongside oil and nuclear and secured eight years of credits. Google signed a 15-year contract, and Bill Gates committed 100 million dollars.tc pixel
See More Positron Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Positron? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Positron and other key companies, straight to your email.

About Positron

Positron (OTCMKTS:POSC) Corporation (OTCMKTS: POSC) is a medical technology company focused on positron emission tomography (PET), a nuclear-imaging technique used to support the diagnosis and management of disease. Its activities include the development, manufacture and distribution of PET imaging systems and related products for healthcare providers.

The company has emphasized cardiac PET imaging, an application that can help physicians evaluate heart function and blood flow. Positron’s product offerings have included dedicated PET equipment, such as the Attrius PET system, along with related imaging and radiopharmaceutical solutions. The company’s publicly available information provides limited detail about its current geographic markets and leadership.

View Positron Profile